1. |
Fagin JA, Mitsiades N. Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab, 2008, 22(6): 955-969.
|
2. |
Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab, 2002, 87(5): 1941-1946.
|
3. |
Lin JD, Hsueh C, Chao TC. Long-term follow-up of the therapeutic outcomes for papillary thyroid carcinoma with distant metastasis. Medicine (Baltimore), 2015, 94(26): 1058-1063.
|
4. |
Witt RL. What is the best treatment of incidental papillary thyroid microcarcinoma? Laryngoscope, 2016, 126(10): 2203-2204.
|
5. |
Hughes DT, Miller BS, Cohen MS, et al. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin. Ann Surg Oncol, 2014, 21(5): 1647-1652.
|
6. |
Lee CW, Roh JL, Gong G, et al. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann Surg Oncol, 2015, 22(1): 117-124.
|
7. |
Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg, 2003, 237(3): 399-407.
|
8. |
Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg, 2007, 245(4): 604-610.
|
9. |
Ito Y, Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg, 2007, 31(5): 905-915.
|
10. |
Haugen BR. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? Cancer, 2017, 123(3): 372-381.
|
11. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
|
12. |
王伟. 介绍一种评价临床检验结果一致性的的新指标-Kappa 值. 天津医药, 1991, 19(10): 639-640.
|
13. |
Frangos S, Iakovou IP, Marlowe RJ, et al. Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients. Eur J Nucl Med Mol Imaging, 2017, 44(2): 185-189.
|
14. |
程若川. 2015 年版较 2009 年版 ATA 指南对甲状腺乳头状癌的手术治疗变化及解读. 中国普外基础与临床杂志, 2016, 23(10): 1166-1168.
|
15. |
Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg, 2014, 140(4): 317-322.
|
16. |
Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2 444 consecutively treated patients. World J Surg, 2002, 26(8): 879-885.
|
17. |
Wong KP, Lang BH. The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies. J Oncol, 2011, 2011: 127929.
|
18. |
Sippel RS, Chen H. Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid, 2009, 19(12): 1373-1380.
|
19. |
兰霞斌, 张浩. 《2015美国甲状腺协会成人甲状腺结节与分化型甲状腺癌诊治指南》外科治疗更新解读. 中华外科杂志, 2016, 54(3): 172-176.
|
20. |
高明. 甲状腺结节和分化型甲状腺癌诊治指南. 中国肿瘤临床, 2012, 39(17): 1249-1272.
|
21. |
Hegde A, Gopinathan A, Abu Bakar R, et al. A method in the madness in ultrasound evaluation of thyroid nodules. Singapore Med J, 2012, 53(11): 766-773.
|
22. |
Riemann B, Krämer JA, Schmid KW, et al. Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial. Nuklearmedizin, 2010, 49(3): 79-84.
|
23. |
Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol, 2000, 13(2): 123-130.
|
24. |
Ito Y, Kudo T, Takamura Y, et al. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J Surg, 2012, 36(3): 593-597.
|
25. |
Momesso DP, Tuttle RM. Update on differentiated thyroid cancer staging. Endocrinol Metab Clin North Am, 2014, 43(2): 401-421.
|
26. |
刘晓莉, 孙辉. 甲状腺乳头状微小癌的术后管理及动态风险评估. 中华内分泌外科杂志, 2016, 10(4): 265-268.
|